AI-Native Scoping Reviews & Evidence Mapping

Built on 1,032 linked references, this review maps the full exoskeleton evidence landscape—from stroke and spinal cord injury rehabilitation to occupational support, mobility assistance, human augmentation, control systems, and real-world adoption. The full read reveals where exoskeletons genuinely improve function and reduce physical burden, where benefits remain task- and user-dependent, and which barriers still prevent broad clinical and industrial implementation.

Built on 810 linked references, this review maps the evidence on Ebola virus disease — from vaccines and monoclonal antibodies to relapse, viral persistence, survivor sequelae, diagnostics, outbreak control, and hidden system failures — making the full read valuable for anyone who wants the whole Ebola evidence landscape in one place.

PCSK9 is no longer just an LDL-receptor story: this review maps 642 references on its role across lipid lowering, cardiovascular outcomes, inflammation, thrombosis, metabolism, kidney disease, neurobiology, pregnancy, and cancer immunity. The full read shows where PCSK9 inhibition is already clinically strong, where pleiotropic effects may open new therapeutic fields, and where safety or access barriers still limit translation.

GAE shows a strong 6-month pain-relief signal in single-arm studies, but conflicting sham-controlled trials challenge whether the benefit truly lasts beyond placebo at 1 year. The full review explains who may actually benefit, why less advanced radiographic arthritis predicts response, how embolic agents differ, and whether this minimally invasive option deserves a place in the knee OA treatment pathway.

Central venous catheter infection prevention is not a single-product story: this review shows that sustained CLABSI/CRBSI reduction depends on maintenance bundles, chlorhexidine-based care, closed-access systems, daily line-necessity review, staff competency, and audit feedback working together. Built from 326 original studies and 608,263 participant/sample observations, the full read maps where infection rates fall by 42% to over 90%, where risk persists despite bundles, and which maintenance strategies are most clinically actionable across adult, pediatric, neonatal, oncology, and hemodialysis populations.